These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11194428)

  • 1. The utilisation of nuchal translucency as a prenatal marker of Down syndrome, 1993-1999.
    Mulvey SF; Atchison WG; Grimwade JC; Renou PM; Shekleton PA; Wallace EM
    Aust N Z J Obstet Gynaecol; 2000 Nov; 40(4):423-6. PubMed ID: 11194428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuchal translucency and first trimester biochemical markers for down syndrome screening: a cost-effectiveness analysis.
    Caughey AB; Kuppermann M; Norton ME; Washington AE
    Am J Obstet Gynecol; 2002 Nov; 187(5):1239-45. PubMed ID: 12439512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuchal translucency measurement in first trimester Down syndrome screening.
    Scott A
    Issues Emerg Health Technol; 2007 Jun; (100):1-6. PubMed ID: 17595751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for Down syndrome using first-trimester ultrasound and second-trimester maternal serum markers in a low-risk population: a prospective longitudinal study.
    Audibert F; Dommergues M; Benattar C; Taieb J; Thalabard JC; Frydman R
    Ultrasound Obstet Gynecol; 2001 Jul; 18(1):26-31. PubMed ID: 11489221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimising the timing for nuchal translucency measurement.
    Mulvey S; Baker L; Edwards A; Oldham J; Shekleton P; Wallace EM
    Prenat Diagn; 2002 Sep; 22(9):775-7. PubMed ID: 12224069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First trimester nuchal translucency: effective routine screening for Down's syndrome.
    Thilaganathan B; Sairam S; Michailidis G; Wathen NC
    Br J Radiol; 1999 Oct; 72(862):946-8. PubMed ID: 10673944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-trimester screening for Down syndrome in France combining fetal nuchal translucency measurement and biochemical markers.
    Muller F; Benattar C; Audibert F; Roussel N; Dreux S; Cuckle H
    Prenat Diagn; 2003 Oct; 23(10):833-6. PubMed ID: 14558029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population.
    Pajkrt E; van Lith JM; Mol BW; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):163-9. PubMed ID: 9793187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective evaluation of a first trimester screening program for Down syndrome and other chromosomal abnormalities using maternal age, nuchal translucency and biochemistry in an Australian population.
    Scott F; Peters H; Bonifacio M; McLennan A; Boogert A; Kesby G; Anderson J
    Aust N Z J Obstet Gynaecol; 2004 Jun; 44(3):205-9. PubMed ID: 15191443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of first-trimester nuchal translucency on second-trimester maternal serum biochemical screening for Down's syndrome.
    Thilaganathan B; Slack A; Wathen NC
    Ultrasound Obstet Gynecol; 1997 Oct; 10(4):261-4. PubMed ID: 9383877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Screening for trisomy 21 by measuring nuchal translucency during the first trimester of pregnancy].
    Charasson T; Ko-Kivok-Yun P; Martin F; Sarramon MF
    J Gynecol Obstet Biol Reprod (Paris); 1997; 26(7):671-8. PubMed ID: 9471429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased first trimester nuchal translucency: pregnancy and infant outcomes after routine screening for Down's syndrome in an unselected antenatal population.
    Adekunle O; Gopee A; el-Sayed M; Thilaganathan B
    Br J Radiol; 1999 May; 72(857):457-60. PubMed ID: 10505009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of image size on nuchal translucency measurement.
    Edwards A; Mulvey S; Wallace EM
    Prenat Diagn; 2003 Apr; 23(4):284-6. PubMed ID: 12673630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential screening for trisomy 21 by nuchal translucency measurement in the first trimester and maternal serum biochemistry in the second trimester in a low-risk population.
    Schuchter K; Hafner E; Stangl G; Ogris E; Philipp K
    Ultrasound Obstet Gynecol; 2001 Jul; 18(1):23-5. PubMed ID: 11489220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the genetic sonogram in the United States in 2001 and 2007.
    Fang YM; Benn P; Egan JF
    J Ultrasound Med; 2008 Nov; 27(11):1543-8. PubMed ID: 18946092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of nuchal translucency image-scoring method during ongoing audit.
    Herman A; Dreazen E; Maymon R; Tovbin Y; Bukovsky I; Weinraub Z
    Ultrasound Obstet Gynecol; 1999 Dec; 14(6):388-92. PubMed ID: 10658276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Down syndrome screening by ultrasound].
    Rozenberg P
    Gynecol Obstet Fertil; 2005; 33(7-8):526-32. PubMed ID: 16005667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Centre-specific ultrasound nuchal translucency medians needed for Down syndrome screening.
    Logghe H; Cuckle H; Sehmi I
    Prenat Diagn; 2003 May; 23(5):389-92. PubMed ID: 12749036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison and integration of first trimester fetal nuchal translucency and second trimester maternal serum screening for fetal Down syndrome.
    Lam YH; Lee CP; Sin SY; Tang R; Wong HS; Wong SF; Fong DY; Tang MH; Woo HH
    Prenat Diagn; 2002 Aug; 22(8):730-5. PubMed ID: 12210586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.